Dimethyl fumarate ameliorates chemotherapy agent-induced neurotoxicity in vitro

Takehiro Kawashiri, Anna Miyagi, Shiori Shimizu, Nao Shigematsu, Daisuke Kobayashi, Takao Shimazoe

研究成果: Contribution to journalArticle

10 引用 (Scopus)


Chemotherapy agents such as oxaliplatin, cisplatin, paclitaxel, and bortezomib frequently cause severe peripheral neuropathy and there is currently no effective strategy to prevent this. Dimethyl fumarate (DMF) is a new oral drug for the treatment of multiple sclerosis, and has neuroprotective effects via up-regulation of the nuclear factor-erythroid-2-related factor 2 (Nrf2)-dependent antioxidant response. In this study, we investigated the effect of DMF on chemotherapy agent-induced neurodegenerations in cultured cells. We found that DMF and its metabolite monomethyl fumarate (MMF) attenuated oxaliplatin-, cisplatin-, and bortezomib- (but not paclitaxel-) induced inhibition of neurite outgrowth, but had no effect on cell death as a result of these agents in cultured PC12 cells and primary cultured rat dorsal root ganglion (DRG) neurons. Furthermore, Nrf2 DNA binding activity was increased by DMF and MMF in PC12 cells. These findings suggest that DMF, which activates Nrf2 pathway, has a potential protective action against chemotherapy-induced neurotoxicity, particularly neurite impairments.

ジャーナルJournal of Pharmacological Sciences
出版物ステータス出版済み - 6 2018

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

フィンガープリント Dimethyl fumarate ameliorates chemotherapy agent-induced neurotoxicity in vitro' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用